Pertussis vaccination : acellular pertussis vaccine for the fourth and fifth doses of the DTP series update to supplementary ACIP statement. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Superseded

This Document Has Been Replaced By: Pertussis vaccination : use of acellular pertussis vaccines among infants and young children : recommendations of the Advisory Committee on Immunization Practices (ACIP).

Pertussis vaccination : acellular pertussis vaccine for the fourth and fifth doses of the DTP series update to supplementary ACIP statement. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

October 9, 1992
By United States. Advisory Committee on Immunization Practices.
Source: MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 1992; 41(RR-15):1-5.

[PDF-302.62 KB]

English

Details You May Also Like

Details:

Alternative Title:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control
Corporate Authors:

United States. Advisory Committee on Immunization Practices.
Description:

General recommendations on pertussis prevention were issued August 8, 1991, in the ACIP statement on diphtheria, tetanus, and pertussis (1). A supplementary statement on the use of diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP) was issued February 7, 1992 (2) after the licensure of ACEL-IMUNE, prepared by Lederle Laboratories. With the recent licensure of a second DTaP product, Tripedia, this statement updates the supplement. Tripedia has a formulation that differs from that of ACEL-IMUNE. Both DTaP vaccines are licensed for use only as the fourth and/or fifth doses of diphtheria, tetanus, and pertussis vaccination; they are not licensed for the initial three-dose series for infants and children, regardless of age. Whole-cell DTP should continue to be used for the initial three-dose series and remains an acceptable alternative for the fourth and fifth doses. For details on the background, indications, use, and precautions and contraindications of DTaP, refer to the earlier supplementary statement (2).
Subjects:

[+]

Antibodies, Bacterial Bordetella Pertussis Child Child, Preschool Diphtheria-Tetanus-Pertussis Vaccine Humans Immunization, Secondary Infant Pertussis Vaccine Vaccines, Synthetic
Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 1992; 41(RR-15):1-5.
Pubmed ID:

1406564
Document Type:

Journal Article
Place as Subject:

United States
Volume:

41
Issue:

15
Collection(s):

Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR) Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:09bc5e94b4528510d06f81b58f399ce9b4ecd6af47ea0204aa4e7f300e72b588
Download URL:

https://stacks.cdc.gov/view/cdc/7405/cdc_7405_DS1.pdf
File Type:

No Additional Files

More +

Superseded

Pertussis vaccination : acellular pertussis vaccine for the fourth and fifth doses of the DTP series update to supplementary ACIP statement. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Details:

Supporting Files

You May Also Like